Seizert Capital Partners LLC Sells 1,204 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Seizert Capital Partners LLC trimmed its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 2.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 56,355 shares of the company’s stock after selling 1,204 shares during the quarter. Seizert Capital Partners LLC’s holdings in Prestige Consumer Healthcare were worth $4,401,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in PBH. Allspring Global Investments Holdings LLC lifted its position in shares of Prestige Consumer Healthcare by 3.1% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company’s stock worth $126,274,000 after purchasing an additional 49,331 shares in the last quarter. Geode Capital Management LLC raised its position in Prestige Consumer Healthcare by 4.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock worth $95,678,000 after purchasing an additional 50,961 shares during the last quarter. Congress Asset Management Co. lifted its holdings in Prestige Consumer Healthcare by 5.0% during the 4th quarter. Congress Asset Management Co. now owns 908,742 shares of the company’s stock worth $70,964,000 after buying an additional 43,619 shares in the last quarter. Boston Trust Walden Corp boosted its position in Prestige Consumer Healthcare by 43.5% in the 4th quarter. Boston Trust Walden Corp now owns 831,627 shares of the company’s stock valued at $64,942,000 after buying an additional 252,089 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of Prestige Consumer Healthcare by 5.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company’s stock valued at $49,667,000 after buying an additional 33,844 shares during the period. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Down 1.0 %

Shares of NYSE:PBH opened at $84.39 on Wednesday. The company has a 50 day moving average price of $80.29 and a two-hundred day moving average price of $77.51. The company has a market capitalization of $4.18 billion, a PE ratio of 19.76, a PEG ratio of 2.69 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $88.36. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently issued reports on PBH. DA Davidson raised their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a report on Friday, February 7th. Oppenheimer lifted their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research report on Thursday, February 13th. Canaccord Genuity Group increased their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a report on Friday, February 7th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Finally, Raymond James raised Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.60.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.